An increase of the ALS levels concomitant with a decrease of IGFBP-3 has been reported in mice with liver-specific inactivation of the IGF-I gene [7], that will potentially modify the distribution of the IGF-I between the ternary and binary complexes and the free IGF-I pool. The gene discussed is IGF1; the disease is amyotrophic lateral sclerosis.